Company page
Macrogenics, Inc.
Macrogenics, Inc. (ticker: MGNX) is a public company based in America with a market capitalization of approximately $235.2 million. The company focuses on developing innovative therapies for cancer and other serious diseases. Macrogenics aims to advance its pipeline of biologic therapies to improve patient outcomes.
- Ticker
- MGNX:NASDAQ
- Asset type
- Stock
- Market cap
- $254.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD